Activated partial thromboplastin time (aPTT) =< 1.5 x ULN
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN
Activated partial thromboplastin time (aPTT) =< 1.2 X ULN
Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Activated partial thromboplastin time (aPTT) =< 1.5 x institutional ULN (for participants on anticoagulation therapy, =< 1.5 x their baseline value)
Activated partial thromboplastin time (aPTT) =< 1.5 x institutional ULN (for participants on anticoagulation therapy, =< 1.5 x their baseline value)
Activated partial thromboplastin time (aPTT) within normal limits
PTT or activated partial thromboplastin time (aPTT) ?5 seconds above institutional ULN
Activated partial thromboplastin time (aPTT) ?1.5 × ULN (Grade ?1).
Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Activated partial thromboplastin time/ partial thromboplastin time (aPTT/PTT) ? 1.5 x ULN
Activated partial thromboplastin time (aPTT) > 35.9 seconds
Partial thromboplastin time (PTT)/activated (a)PTT =< 1.5 X institutional ULN normal except if, in the opinion of the investigator, the aPTT is elevated because of a positive lupus anticoagulant (unless dysfunction is secondary to lymphoma involvement)
Activated partial thromboplastin time (aPTT) =< 1.5 X ULN
Partial thromboplastin time (PTT) or activated PTT (aPTT) =< 1.5 x ULN
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin) (obtained within 28 days prior to first study treatment)
Activated partial thromboplastin time (aPTT) within 1.25 x ULN institutional limits, except where a lupus anti-coagulant has been confirmed
Activated partial thromboplastin time (aPTT) < 1.5 x ULN
Partial thromboplastin time (PTT) (PTT/activated partial thromboplastin time [aPTT]) < 1.5 x ULN)
Within 3 months of registration: Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin)
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN for the laboratory
Activated partial thromboplastin time (aPTT) =< 1.2 x IULN
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN unless the patient is receiving anticoagulant therapy
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN
Activated partial thromboplastin time/ partial thromboplastin time (aPTT/PTT) ?1.5 x ULN
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN or within therapeutic range if receiving anticoagulant therapy OR
Activated partial thromboplastin time (APTT)/PTT =< 1.5 x institutional ULN
Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x ULN
Activated partial thromboplastin time (aPTT) =< 1.5 x ULN for the laboratory
ARM A: obtained =< 14 days prior to registration: \r\n* Activated partial thromboplastin time (aPTT) =< 1.5 x ULN
Obtained within 30 days prior to registration: Activated partial thromboplastin time (aPTT) =< 2 x ULN (Note: use of vitamin K antagonist is not allowed)
Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN
Activated partial thromboplastin time (APTT) < 1.2 times upper limit of normal (ULN); (Note: use of warfarin is prohibited; low molecular weight heparin is allowed, so long as these criteria are met)
Activated Partial Thromboplastin Time (APTT) patients beeing treated with anticoagulants are excluded if teh coagulation parameters are outside the therapeutic intervals as described in the SmPC/USPI for the administered treatment
Activated Partial Thromboplastin Time (aPTT) ?1.5 X ULN
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN (tested within 14 days prior to registration)
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN
Activated partial thromboplastin time (aPTT) =< 1.2 x IULN
Partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT) =< upper limit of normal (ULN) per institutional laboratory range
Activated partial thromboplastin time (aPTT) > 1.5 x ULN (patients on heparin treatment must have an aPTT between 1.5 - 2.5 x ULN), or
Activated partial thromboplastin time (aPTT) =< 1.5 x institutional upper limits of normal
Activated partial thromboplastin time (aPTT) =< 1.2 X ULN; subjects receiving anticoagulant therapy are eligible if their aPTT is stable and within the recommended range for the desired level of anticoagulation
Activated partial thromboplastin time (aPTT) =< 1.2 X ULN
Activated partial thromboplastin time (aPTT) =< 1.2 X ULN
Activated partial thromboplastin time (aPTT) =< 1.2 X ULN
Activated partial thromboplastin time (aPTT) =< 1.2 x ULN
Prothrombin time and activated partial thromboplastin time (aPTT) < 1.5 times the upper limit of normal (ULN)
Activated partial thromboplastin time (aPTT) ? 1.5 x the upper limit of the normal range (ULN) per institutional laboratory normal range
Activated partial thromboplastin time (aPTT) ? 1.5 x the upper limit of the normal range (ULN) per institutional laboratory normal range
Activated partial thromboplastin time (APTT) =< 1.5 x upper limit of normal unless patient is receiving anticoagulants; if patient is on anticoagulation therapy, levels should be within therapeutic range
Activated partial thromboplastin time (PTT) < 1.5 x ULN
Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
aPTT ? 1.5 x ULN
Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Activated partial thromboplastin time =< 1.5 times ULN
Activated partial thromboplastin time =< 1.5 times ULN
Activated partial thromboplastin time (aPTT) ? 1.3 × ULN
Abnormal coagulation (partial thromboplastin [PT] or activated partial thromboplastin time [aPTT] > 30% above normal limits)
Within 30 days of surgery: Activated partial thromboplastin time (aPTT) =< 40
Activated partial thromboplastin time (APTT) or partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Partial thromboplastin time (PTT) (activated partial thromboplastin time [aPTT]) =< 1.5 times the upper limit of normal
Activated partial thromboplastin time (aPTT) =< 40 (within 30 days of surgery)
Activated partial thromboplastin time (aPTT) within normal institutional limits
Activated partial thromboplastin time (APTT)/partial thromboplastin time (PTT) =< 1.5 x institutional upper limit of normal
Obtained within 28 days prior to registration: Activated partial thromboplastin time (aPTT) =< 1.5 x ULN (unless on prophylactic or therapeutic dosing with low molecular weight heparin)
Activated partial thromboplastin time (aPTT) or plasma thromboplastin (PT) outside the institution's standard of care.
